October 17, 2017Comments Off on Trump says he could jettison drug czar pick
WASHINGTON (Reuters) – U.S. President Donald Trump said on Monday he would review a report that his nominee for drug czar championed a law that weakened the government’s ability to... Read More
October 11, 2017Comments Off on Pharma’s Puerto Rico problems could mean drug shortages: FDA chief
NEW YORK (Reuters) – The head of the U.S. Food and Drug Administration said on Tuesday the country may start to see a small number of drug shortages within two... Read More
October 10, 2017Comments Off on California governor signs drug pricing transparency law
(Reuters) – California Governor Jerry Brown on Monday signed state legislation requiring drug companies to report certain price hikes for prescription medicines in a move that could set a model... Read More
October 9, 2017Comments Off on China to speed up drug approvals, will accept overseas trial data
SHANGHAI (Reuters) – China is looking to speed up approvals for new drugs and plans to accept data from clinical trials carried out overseas, a potential boon for international drugmakers... Read More
October 7, 2017Comments Off on Drug chains tumble on reports Amazon eyeing their pie
(Reuters) – Shares of drug retailers Walgreens Boots Alliance Inc , CVS Health Corp and Rite Aid Corp tumbled on Friday after reports that Amazon.com Inc was looking to make... Read More
September 28, 2017Comments Off on Novartis forges UC Berkeley pact, sees drug hopefuls in three years
ZURICH (Reuters) – Novartis’s NOVN.S research head expects an alliance with a University of California chemistry lab to produce drug candidates within three years as the Swiss company accelerates its... Read More
September 23, 2017Comments Off on Japan health minister to consider U.S. drug firms’ views in pricing overhaul
TOKYO (Reuters) – Japan will weigh the concerns of U.S. drug firms in its efforts to complete by year-end a drastic revision of its drug-pricing system, aimed at reining in... Read More
September 16, 2017Comments Off on Drug industry on tenterhooks as Maryland price-gouging law nears
(Reuters) – As U.S. consumer outrage grows over prescription drug prices, state authorities and patient advocates in Maryland are preparing to enforce the nation’s first law designed to punish drugmaker... Read More
September 15, 2017Comments Off on Pfizer, Astellas prostate cancer drug promising in late-stage trial
(Reuters) – Pfizer Inc and Japan’s Astellas Pharma Inc said on Thursday their blockbuster prostate cancer drug met the main goal of a key study that tested it for treating... Read More
September 10, 2017Comments Off on AstraZeneca rebuilds cancer drug hopes with new lung data
MADRID (Reuters) – Two AstraZeneca drugs tackling lung cancer in different ways delivered impressive clinical results on Saturday, helping the British group offset July’s big clinical trial setback in the... Read More
